Hyperuricemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients over 18 years old with hyperuricemia or non-hyperuricemia who were hospitalized in the Department of Endocrinology of our hospital during the study period; 2. Willing to provide demographic information such as name, gender, age, contact number, and physical measurement data such as height, weight, waist circumference, hip circumference, and blood pressure; 3. EGFR >= 60ml/min/1.73m^2 and serum creatinine < 177umol/L (2mg/ dL); 4. Patients who are willing to sign informed consent, cooperate with this study and keep relevant specimens.
Exclusion criteria
Exclusion criteria: 1. Current or previous diseases affecting uric acid metabolism (massive proteinuria, hematuria, leukemia, leukocytosis, multiple myeloma, chronic hemolytic anemia, polycythemia, myeloproliferative diseases, diabetes insipidus, malignant tumors, radiotherapy and chemotherapy, etc.); 2. Taking drugs that affect uric acid metabolism (diuretics, allopurinol, phenbromarone, sodium bicarbonate, aspirin, ethambutol, pyrazinamide, niacin, ethanol, cyclosporine, etc.) in the past one month; 3. Patients who are not willing to cooperate with the clinical study to keep urine and blood samples, with incomplete data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood uric acid;urate acid of urine;creatitine of blood;creatitine of urine; | — |
Countries
China
Contacts
Zhongshan Hospital, Fudan University